Low dose amitriptyline versus cognitive behavioral therapy for insomnia in patients with medical comorbidity: results of a randomized controlled multicenter non inferiority trial
Sleep · 2025
DOI: 10.1093/sleep/zsaf176 ↗Kurz gefasst
Äquivalenzstudie in der Zeitschrift Sleep, 2025. Verfasst von Nynke Rauwerda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Psychology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Amitriptyline, Cognitive Behavioral Therapy, Sleep Initiation and Maintenance Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Gelderse Vallei, Ede, The Netherlands.
Themen: Schlaf
Abstract (Originalsprache)
Study objectives In a randomized controlled non-inferiority trial, we aimed to determine whether low dose Amitriptyline (AM), which is often used off-label, is a safe and effective alternative to cognitive behavioral therapy for insomnia (CBT-I) in the treatment of insomnia among patients with insomnia and medical comorbidity.
Methods
A total of 187 participants with insomnia and medical comorbidity were randomly allocated to either: 1) 12 weeks of AM, 10-20 mg (n = 93), or 2) 12 weeks of group CBT-I, 7 sessions (n = 94). Assessments took place at baseline, 6 and 12 weeks after start of treatment. The primary non-inferiority outcome was insomnia severity (Insomnia Severity Index; ISI) at 12 weeks.
Results
Based on a non-inferiority margin of four points on the ISI, AM was non-inferior to CBT-I at 12 weeks of treatment (mean difference of 1.1 points; 95% CI -0.5 to 2.8). Secondary analyses showed that significantly more CBT-I participants reached a clinical response (≥ 8-point reduction on the ISI) than AM participants (58% versus 41%, p=.02). AM participants reported more side-effects (mostly anticholinergic) at 12 weeks treatment (p<.001) than participants who received CBT-I. After discontinuation 68% of the AM participants reported worsening of sleep. In 12% of them this worsening was temporarily.
Conclusions
With a liberal non-inferiority margin, AM is non-inferior to CBT-I in reducing insomnia severity. AM has more side effects and its effect on insomnia may diminish after tapering. CBT-I should remain first-line treatment for patients with medical comorbidity given its broader benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Psychology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Medical Psychology, Hospital Gelderse Vallei, Ede, The Netherlands.
- Department of Clinical Psychology & Amsterdam Public Health Research Institute, VU University, Amsterdam, The Netherlands.
- Department of Medical Psychology, Zaans Medical Center, Zaandam The Netherlands.
- Department of Neurology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands.
- Department of Neurology, Hospital Gelderse Vallei, Ede, The Netherlands.
ORCID-Profile: Nynke Rauwerda, Annemieke van Straten, Marcel Smits, Pythia Nieuwkerk, Annemarie Braamse, Hans Knoop
Förderung
- Hospital Gelderse Vallei, Ede, The Netherlands
Zitieren
APA
Rauwerda, N., van Straten, A., Zondervan, A., Timmerhuis, T., Smits, M., Nieuwkerk, P., Braamse, A., Boss, H. M., & Knoop, H. (2025). Low dose amitriptyline versus cognitive behavioral therapy for insomnia in patients with medical comorbidity: results of a randomized controlled multicenter non inferiority trial. Sleep. https://doi.org/10.1093/sleep/zsaf176
Vancouver
Rauwerda N, van Straten A, Zondervan A, Timmerhuis T, Smits M, Nieuwkerk P, et al. Low dose amitriptyline versus cognitive behavioral therapy for insomnia in patients with medical comorbidity: results of a randomized controlled multicenter non inferiority trial. Sleep. 2025. doi:10.1093/sleep/zsaf176
BibTeX
@article{Rauwerda2025,
author = {Rauwerda, Nynke and van Straten, Annemieke and Zondervan, Anouk and Timmerhuis, Thom and Smits, Marcel and Nieuwkerk, Pythia and Braamse, Annemarie and Boss, H Myrthe and Knoop, Hans},
title = {Low dose amitriptyline versus cognitive behavioral therapy for insomnia in patients with medical comorbidity: results of a randomized controlled multicenter non inferiority trial},
journal = {Sleep},
year = {2025},
doi = {10.1093/sleep/zsaf176}
}
EUVIMED